Furthermore, our data provide evidence that PDGFRα+ fibroblast loss favors the creation of neutrophilic conditions, accelerating asthma pathology through excessive mucus production, facilitated ECM alteration and increased NETs within the lung. This evidence concerns the gene PDGFRA and asthma.